Targeting the EGFR-SGLT1 interaction for cancer therapy

• 收藏
• 分享

专利权人:

The University of Houston System

发明人:

Zhang Weihua

申请号：

US14273375

公开号：

US09334307B2

申请日:

2014.05.08

申请国别(地区):

US

年份:

2016

代理人:

摘要：

A compound can destabilize a binding interaction between an epidermal growth factor receptor (EGFR) and a sodium/glucose co-transporter 1 (SGLT 1). In one embodiment, the compound is a peptide derived from the interacting domain of EGFR. In another embodiment, the peptide is administered to a patient to treat cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/